General Information of the Compound
| Compound ID |
CP0547226
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[[(1S,3aS,5aR,5bR,7aR,9R,11aR,11bR,13aR,13bR)-9-(cyclopropylcarbamoyloxy)-5a,5b,8,8,11a-pentamethyl-1-propan-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]carbamoyloxy]acetic acid
Show/Hide
|
||||||||||||||||||
| Formula |
C36H58N2O6
|
||||||||||||||||||
| Molecular Weight |
614.868
|
||||||||||||||||||
| Canonical SMILES |
CC(C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@@H](OC(=O)NC6CC6)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)NC(=O)OCC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H58N2O6/c1-21(2)23-12-17-36(38-31(42)43-20-28(39)40)19-18-34(6)24(29(23)36)10-11-26-33(5)15-14-27(44-30(41)37-22-8-9-22)32(3,4)25(33)13-16-35(26,34)7/h21-27,29H,8-20H2,1-7H3,(H,37,41)(H,38,42)(H,39,40)/t23-,24+,25-,26+,27+,29+,33-,34+,35+,36-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XGUNIXWMPRGBRI-JAZUPRQQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound